BRPI0719961A2 - Clonagem, expressão e uso de lisofosfolipase de ácido - Google Patents

Clonagem, expressão e uso de lisofosfolipase de ácido

Info

Publication number
BRPI0719961A2
BRPI0719961A2 BRPI0719961-9A2A BRPI0719961A BRPI0719961A2 BR PI0719961 A2 BRPI0719961 A2 BR PI0719961A2 BR PI0719961 A BRPI0719961 A BR PI0719961A BR PI0719961 A2 BRPI0719961 A2 BR PI0719961A2
Authority
BR
Brazil
Prior art keywords
lysophospholipase
cloning
expression
acid
acid lysophospholipase
Prior art date
Application number
BRPI0719961-9A2A
Other languages
English (en)
Inventor
Khanh Q Nguyen
Volker Marschner
Kornelia Titze
Bruno Winter
Original Assignee
Ab Enzymes Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Enzymes Gmbh filed Critical Ab Enzymes Gmbh
Publication of BRPI0719961A2 publication Critical patent/BRPI0719961A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01005—Lysophospholipase (3.1.1.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0719961-9A2A 2006-10-02 2007-09-21 Clonagem, expressão e uso de lisofosfolipase de ácido BRPI0719961A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006046857A DE102006046857A1 (de) 2006-10-02 2006-10-02 Klonierung, Expression und Verwendung saurer Lysophospholipasen
PCT/EP2007/008256 WO2008040465A1 (de) 2006-10-02 2007-09-21 Klonierung, expression und verwendung saurer lysophospholipasen

Publications (1)

Publication Number Publication Date
BRPI0719961A2 true BRPI0719961A2 (pt) 2014-04-29

Family

ID=38829190

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719961-9A2A BRPI0719961A2 (pt) 2006-10-02 2007-09-21 Clonagem, expressão e uso de lisofosfolipase de ácido

Country Status (11)

Country Link
US (2) US8202715B2 (pt)
EP (1) EP2084272B1 (pt)
AU (1) AU2007304532B9 (pt)
BR (1) BRPI0719961A2 (pt)
CA (1) CA2667064C (pt)
DE (1) DE102006046857A1 (pt)
DK (1) DK2084272T3 (pt)
ES (1) ES2574089T3 (pt)
HU (1) HUE030279T2 (pt)
PL (1) PL2084272T3 (pt)
WO (1) WO2008040465A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009051013A1 (de) 2009-10-28 2011-06-09 Ab Enzymes Gmbh Klonierung, Expression und Verwendung saurer Phospholipasen
PL2545150T3 (pl) 2010-03-12 2019-01-31 Dupont Nutrition Biosciences Aps Sposób
WO2012114232A1 (en) 2011-02-23 2012-08-30 Dupont Nutrition Biosciences Aps Process
WO2013104660A1 (en) 2012-01-13 2013-07-18 Dupont Nutrition Biosciences Aps Process for treating a plant oil comprising hydrolysing chlorophyll or a chlorophyll derivative and involving partial caustic neutralisation
JP7752247B2 (ja) * 2021-12-23 2025-10-09 豊益（上海）生物技術研発中心有限公司 変異リゾホスホリパーゼおよび該酵素を発現するための変異アスペルギルス・ニガー株
CN118685384B (zh) * 2024-08-07 2025-10-17 青岛蔚蓝生物集团有限公司 溶血磷脂酶突变体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525012D0 (en) 1985-10-10 1985-11-13 Cpc International Inc Carbohydrate refining process
US4873192A (en) * 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
JPH03151879A (ja) 1989-11-10 1991-06-28 Toyobo Co Ltd リポプロテインリパーゼの遺伝情報を有するｄｎａ配列
DE4115938A1 (de) 1991-05-16 1992-11-19 Metallgesellschaft Ag Enzymatisches verfahren zur verminderung des gehaltes an phosphorhaltigen bestandteilen in pflanzlichen und tierischen oelen
JP3151879B2 (ja) 1991-10-24 2001-04-03 日本電気株式会社 音声開発装置
PT575133E (pt) * 1992-06-16 2002-11-29 Sankyo Co Nova fosfolipase a1 processo para a sua preparacao e sua utilizacao
DE19620649A1 (de) * 1996-05-22 1997-11-27 Roehm Gmbh Rekombinant hergestellte Lysophospholipase aus Aspergillus
AU4772597A (en) 1996-10-31 1998-05-22 Novo Nordisk A/S Novel phospholipase, production and use thereof
ATE226974T1 (de) 1996-12-09 2002-11-15 Novozymes As Verringerung von phosphorhaltigen substanzen in speiseölen mit hohem anteil an nicht- hydratisierbarem phosphor unter verwendung einer phospholipase, eine phospholipase aus fädenförmigen pilz, welche eine phospholipase a und/oder b-aktivität aufweist
DE19701348A1 (de) 1997-01-16 1998-07-23 Roehm Gmbh Protein mit Phospholipaseaktivität
US7504490B1 (en) * 1998-10-16 2009-03-17 Oscient Pharmaceuticals Corporation Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
WO2000028044A1 (en) 1998-11-10 2000-05-18 Novozymes Biotech, Inc. Polypeptides having lysophospholipase activity and nucleic acids encoding same
WO2000032758A1 (en) 1998-11-27 2000-06-08 Novozymes A/S Lipolytic enzyme variants
ATE494366T1 (de) 1999-10-14 2011-01-15 Novozymes As Lysophospholipase aus aspergillus
US6146869A (en) 1999-10-21 2000-11-14 Novo Nordisk Biotech, Inc. Polypeptides having phospholipase B activity and nucleic acids encoding same
WO2002024881A1 (en) 2000-09-25 2002-03-28 Novozymes A/S Phospholipase from zygoascus hellenicus
WO2002066622A2 (en) 2001-02-23 2002-08-29 Novozymes A/S Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes
EP1468084A1 (en) 2002-01-16 2004-10-20 Novozymes A/S Lipolytic enzyme variants and method for their production
AU2003232821A1 (en) 2002-05-21 2003-12-02 Dsm Ip Assets B.V. Novel phospholipases and uses thereof
CA2522954C (en) 2003-04-28 2014-06-17 Novozymes A/S Phospholipase and method of producing it
EP1639102A2 (en) 2003-06-19 2006-03-29 Novozymes A/S Phospholipase variants

Also Published As

Publication number Publication date
WO2008040465A1 (de) 2008-04-10
US8507241B2 (en) 2013-08-13
EP2084272A1 (de) 2009-08-05
ES2574089T3 (es) 2016-06-14
AU2007304532B2 (en) 2013-10-24
US8202715B2 (en) 2012-06-19
US20120219666A1 (en) 2012-08-30
PL2084272T3 (pl) 2016-10-31
HUE030279T2 (en) 2017-04-28
AU2007304532B9 (en) 2014-04-03
AU2007304532A1 (en) 2008-04-10
EP2084272B1 (de) 2016-04-13
CA2667064A1 (en) 2008-04-10
DK2084272T3 (en) 2016-07-18
DE102006046857A1 (de) 2008-04-03
US20100119656A1 (en) 2010-05-13
CA2667064C (en) 2016-11-01

Similar Documents

Publication Publication Date Title
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0717411A2 (pt) Uso de inibidores de iap
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0818003A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI1005292A2 (pt) composição de decapagem e uso da composição
CR10709A (es) Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
EP2083864A4 (en) ANTAGONISTS OF PCSK9
EP2083859A4 (en) PCSK9 ANTAGONISTS
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
DOP2010000260A (es) Derivado heterociclico fusionado y su uso
EP2046290A4 (en) AQUEOUS DRONABINOL FORMULATIONS
BRPI0812159A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI1005670A8 (pt) composições adjuvantes e processos de uso.
NO20081618L (no) Anvendelse av proteiner som en antiskumdannende komponent i drivstoff
BRPI0922573A2 (pt) composição, e, uso de anidridos de ácidos carboxílicos multifuncionais.
BRPI0913833A2 (pt) uso de corantes ácidos
BRPI0922344A2 (pt) inibidores de tfpi e métodos de uso
BRPI1006996A2 (pt) composição, método e uso

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL